This bill would establish a task force to develop best practices for the use of prescription opioids. It would consider research on pain management, existing evidence-based guidelines, high-risk populations at risk of addiction, and instructions issued by the Centers for Disease Control and Prevention (CDC).
The task force would consider public comments on the best practices it develops, and would be composed of numerous organizations including:
Federal agencies such as the Dept. of Health and Human Services (HHS), the CDC, and the National Institutes of Health among others;
State medical boards;
Physicians, dentists, and nonphysician prescribers;
Pharmacists and pharmacies;
Experts in the fields of pain research and addiction research;
Representatives of the mental health, pain management, and addiction treatment organizations;
A person in recovery from addiction to medication prescribed for chronic pain;
A person with chronic pain;
Other appropriate stakeholders chosen by the HHS Secretary.
The task force would develop a report with all of its findings and suggestions to be submitted to Congress within 270 days of this bill’s enactment, which would include a strategy for getting that information to relevant medical professionals.